Compile Data Set for Download or QSAR
maximum 50k data
Found 105 Enz. Inhib. hit(s) with all data for entry = 5976
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103367(US8552202, Example 4)
Affinity DataKi:  0.400nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103364(US8552202, Compound 13)
Affinity DataKi:  1.70nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103361(US8552202, Example 2)
Affinity DataKi:  2.20nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103358(US8552202, Compound 9)
Affinity DataKi:  3.60nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103354(US8552202, Example 1)
Affinity DataKi:  5nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103351(US8552202, Compound 3)
Affinity DataKi:  8.5nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103363(US8552202, Example 3)
Affinity DataKi:  12nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103366(US8552202, Compound 15)
Affinity DataKi:  15nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103364(US8552202, Compound 13)
Affinity DataKi:  23nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103360(US8552202, Compound 11)
Affinity DataKi:  24nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103358(US8552202, Compound 9)
Affinity DataKi:  27nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103353(US8552202, Compound 5)
Affinity DataKi:  28nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103365(US8552202, Compound 14)
Affinity DataKi:  32nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103351(US8552202, Compound 3)
Affinity DataKi:  35nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103357(US8552202, Compound 8)
Affinity DataKi:  50nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103362(US8552202, Compound 12)
Affinity DataKi:  55nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103350(US8552202, Compound 2)
Affinity DataKi:  59nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103352(US8552202, Compound 4)
Affinity DataKi:  72nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103355(US8552202, Compound 6)
Affinity DataKi:  75nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103359(US8552202, Compound 10)
Affinity DataKi:  79nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103350(US8552202, Compound 2)
Affinity DataKi:  95nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103351(US8552202, Compound 3)
Affinity DataKi:  100nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103351(US8552202, Compound 3)
Affinity DataKi:  100nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103356(US8552202, Compound 7)
Affinity DataKi:  170nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103364(US8552202, Compound 13)
Affinity DataKi:  170nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103349(US8552202, Compound 1)
Affinity DataKi:  225nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103365(US8552202, Compound 14)
Affinity DataKi:  230nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103358(US8552202, Compound 9)
Affinity DataKi:  240nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103364(US8552202, Compound 13)
Affinity DataKi:  270nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103349(US8552202, Compound 1)
Affinity DataKi:  305nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103357(US8552202, Compound 8)
Affinity DataKi:  340nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103364(US8552202, Compound 13)
Affinity DataKi:  440nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103348(US8552202, 63)
Affinity DataKi:  555nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin S(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM34544(US8552202, Compound 38)
Affinity DataKi:  555nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103356(US8552202, Compound 7)
Affinity DataKi:  560nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103350(US8552202, Compound 2)
Affinity DataKi:  580nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103358(US8552202, Compound 9)
Affinity DataKi:  650nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103350(US8552202, Compound 2)
Affinity DataKi:  700nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103351(US8552202, Compound 3)
Affinity DataKi:  780nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM34544(US8552202, Compound 38)
Affinity DataKi: >1.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103358(US8552202, Compound 9)
Affinity DataKi: >1.20E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103349(US8552202, Compound 1)
Affinity DataKi:  1.25E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103354(US8552202, Example 1)
Affinity DataKi:  1.40E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM34544(US8552202, Compound 38)
Affinity DataKi:  1.70E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103348(US8552202, 63)
Affinity DataKi:  1.70E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103363(US8552202, Example 3)
Affinity DataKi:  1.70E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103365(US8552202, Compound 14)
Affinity DataKi:  1.80E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103365(US8552202, Compound 14)
Affinity DataKi:  1.90E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103349(US8552202, Compound 1)
Affinity DataKi:  1.90E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin L2(Homo sapiens (Human))
Amura Therapeutics

US Patent
LigandPNGBDBM103357(US8552202, Compound 8)
Affinity DataKi:  2.00E+3nMAssay Description:In vitro inhibition assay using cathepsin.More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: